Abstract
The identification of biomarkers for patient stratification is fundamental to precision medicine efforts in oncology. Here, we identified two baseline, circulating immune cell subsets associated with overall survival in patients with metastatic pancreatic cancer who were enrolled in two phase II randomized studies of GVAX pancreas and CRS-207 immunotherapy. Single-cell mass cytometry was used to simultaneously measure 38 cell surface or intracellular markers in peripheral blood mononuclear cells obtained from a phase IIa patient subcohort (N = 38). CITRUS, an algorithm for identification of stratifying subpopulations in multidimensional cytometry datasets, was used to identify single-cell signatures associated with clinical outcome. Patients with a higher abundance of CD8+CD45RO-CCR7-CD57+ cells and a lower abundance of CD14+CD33+CD85j+ cells had improved overall survival [median overall survival, range (days) 271, 43-1,247] compared with patients with a lower abundance of CD8+CD45RO-CCR7-CD57+ cells and higher abundance of CD14+CD33+CD85j+ cells (77, 24-1,247 days; P = 0.0442). The results from this prospective-retrospective biomarker analysis were validated by flow cytometry in 200 patients with pancreatic cancer enrolled in ...Continue Reading
References
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Nov 14, 1997·The Journal of Experimental Medicine·D HamannR A van Lier
Nov 7, 2001·BMC Immunology·E H EylarT B Breithaupt
Aug 4, 2004·The Journal of Experimental Medicine·Amy Morck ThomasElizabeth M Jaffee
Sep 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Dirk G BrockstedtThomas W Dubensky
May 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Claudya TencaErmanno Ciccone
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dan LaheruElizabeth Jaffee
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Karen L WoodAndrea I Doseff
Sep 1, 2009·Immunology Letters·Birgit WeinbergerBeatrix Grubeck-Loebenstein
Sep 4, 2009·Clinical and Vaccine Immunology : CVI·D E CampbellS D Douglas
Nov 3, 2009·Journal of Leukocyte Biology·Daniele FocosiMario Petrini
May 10, 2011·Science·Sean C BendallGarry P Nolan
Jun 30, 2011·Immunology·Marius StriogaDainius Characiejus
Dec 8, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dung T LeDaniel A Laheru
Oct 5, 2012·Journal of Translational Medicine·Jérôme GalonBernard A Fox
Dec 21, 2013·Cancer Immunology, Immunotherapy : CII·Christiane MeyerDaniel E Speiser
Feb 6, 2014·PloS One·Ahmad A TarhiniJohn M Kirkwood
Mar 19, 2014·Gut·Tim F Greten
Jul 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·Robert V BruggnerGarry P Nolan
Sep 26, 2014·Science Translational Medicine·Brice GaudillièreGarry P Nolan
Jan 15, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dung T LeElizabeth M Jaffee
Jul 19, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cariad Chester, Holden T Maecker
Jan 21, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alexander MartensBenjamin Weide
Citations
May 4, 2021·Frontiers in Molecular Biosciences·Kue Peng Lim, Nur Syafinaz Zainal
Jul 17, 2021·Nature Reviews. Cardiology·Dawn M Fernandez, Chiara Giannarelli
Aug 28, 2021·Cancers·Philip DujardinBarbara M Grüner
Aug 28, 2021·Cancers·Anna Maxi WandmacherSusanne Sebens